Myriad Genetics Stock Technical Analysis
| MYGN Stock | USD 15.12 0.18 1.18% |
As of the 22nd of November, Myriad Genetics secures the Standard Deviation of 3.43, risk adjusted performance of (0.18), and Mean Deviation of 2.14. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Myriad Genetics, as well as the relationship between them.
Myriad Genetics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Myriad, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MyriadMyriad |
Myriad Genetics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 20.72 | Buy | 14 | Odds |
Most Myriad analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Myriad stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Myriad Genetics, talking to its executives and customers, or listening to Myriad conference calls.
Myriad Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Myriad Genetics Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Myriad Genetics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Myriad Genetics Trend Analysis
Use this graph to draw trend lines for Myriad Genetics. You can use it to identify possible trend reversals for Myriad Genetics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Myriad Genetics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Myriad Genetics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Myriad Genetics applied against its price change over selected period. The best fit line has a slop of 0.24 , which may suggest that Myriad Genetics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 2131.98, which is the sum of squared deviations for the predicted Myriad Genetics price change compared to its average price change.About Myriad Genetics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Myriad Genetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Myriad Genetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Myriad Genetics price pattern first instead of the macroeconomic environment surrounding Myriad Genetics. By analyzing Myriad Genetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Myriad Genetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Myriad Genetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 0.37 | 0.22 | Price To Sales Ratio | 1.98 | 1.88 |
Myriad Genetics November 22, 2024 Technical Indicators
Most technical analysis of Myriad help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Myriad from various momentum indicators to cycle indicators. When you analyze Myriad charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.18) | |||
| Market Risk Adjusted Performance | (1.56) | |||
| Mean Deviation | 2.14 | |||
| Coefficient Of Variation | (396.67) | |||
| Standard Deviation | 3.43 | |||
| Variance | 11.76 | |||
| Information Ratio | (0.28) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (1.32) | |||
| Treynor Ratio | (1.57) | |||
| Maximum Drawdown | 27.15 | |||
| Value At Risk | (6.12) | |||
| Potential Upside | 4.24 | |||
| Skewness | (1.68) | |||
| Kurtosis | 9.72 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 9.205 | Quarterly Revenue Growth 0.112 | Return On Assets (0.05) | Return On Equity (0.16) |
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.